Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ovarian Neoplasms

  Free Subscription

Articles published in
Int J Gynecol Pathol
    March 2024
  1. XU J, McGregor SM, Park KJ, Weisman PS, et al
    Ovarian Endometrioid Adenocarcinomas With Infiltrative "Adenofibroma-like" Morphology and Aberrant ss-catenin Expression: Tumors That Coexpress CDX2 and LEF1 With Frequent Neuroendocrine Marker Expression, Diminished/Lost PAX8 and Possible Association
    Int J Gynecol Pathol. 2024;43:145-148.
    >> Share

  2. BHARDWAJ S, Banet N, Gaston EC
    Moderately-differentiated Ovarian Sertoli-Leydig Cell Tumor With a Concurrent Serous Borderline Tumor in a 16-year-old Girl.
    Int J Gynecol Pathol. 2024;43:140-144.
    >> Share

  3. SMITHGALL MC, Yemelyanova A, Mathew S, Gogineni S, et al
    HER2/ ERBB2 Immunohistochemical Expression and Copy Number Status in Ovarian Mucinous Tumors.
    Int J Gynecol Pathol. 2024;43:134-139.
    >> Share

  4. KENDALL BARTU M, Nemejcova K, Michalkova R, Bui QH, et al
    Neuroendocrine Marker Expression in Primary Non-neuroendocrine Epithelial Tumors of the Ovary: A Study of 551 Cases.
    Int J Gynecol Pathol. 2024;43:123-133.
    >> Share

  5. KANG EY, Terzic T, Ghatage P, Woo L, et al
    TP53 as a Diagnostic Aid in the Distinction of Ovarian Mucinous Borderline Tumors From Mucinous Carcinoma.
    Int J Gynecol Pathol. 2024;43:111-122.
    >> Share

    January 2024
  6. FISCHER EG
    Two Rare Cases of Paratubal Leydig Cell Nodules: Clinical Relevance and Debated Terminology of a Noteworthy Incidentaloma.
    Int J Gynecol Pathol. 2024;43:97-101.
    >> Share

  7. ISE K, Tanei ZI, Oda Y, Tanikawa S, et al
    A Case of Uterine Tumor Resembling Ovarian Sex Cord Tumor With Prominent Myxoid Features.
    Int J Gynecol Pathol. 2024;43:41-46.
    >> Share

  8. WESSMAN S, Fuentes BB, Severin-Karlsson J, Westbom-Fremer S, et al
    FOXL2 Mutation Status in Sex Cord-stromal Tumors Cannot be Predicted by Morphology.
    Int J Gynecol Pathol. 2024;43:78-89.
    >> Share

  9. KAWAGUCHI R, Maehana T, Sugimoto S, Kawahara N, et al
    Immunohistochemical Analysis of the Tissue Factor Pathway Inhibitor-2 in Endometrial Clear Cell Carcinoma: A Single-center Retrospective Study.
    Int J Gynecol Pathol. 2024;43:25-32.
    >> Share

  10. XU J, Park KJ, Weisman PS
    An Expanded Series of Pilomatrix-like High-grade Endometrioid Carcinoma (PiMHEC), Including Both MMR Deficient and MMR Proficient Cases.
    Int J Gynecol Pathol. 2024;43:67-69.
    >> Share

  11. ELMUTI L, Amundson J, Oberman E, Kamat A, et al
    Diffuse Pediatric-type High-grade Glioma Arising in an Ovarian Mature Cystic Teratoma.
    Int J Gynecol Pathol. 2024;43:90-96.
    >> Share

  12. WEPY C, Nucci MR, Parra-Herran C
    Atypical Endometriosis: Comprehensive Characterization of Clinicopathologic, Immunohistochemical, and Molecular Features.
    Int J Gynecol Pathol. 2024;43:70-77.
    >> Share

    November 2023
  13. YOSHINO Y, Yanai S, Sawada M, Sakate S, et al
    Extraovarian Dysgerminoma Involving the Uterine Cervix: A Rare Case Report With Literature Review.
    Int J Gynecol Pathol. 2023;42:544-549.
    >> Share

  14. MATSUMOTO N, Manrai P, Rottmann D, Wu X, et al
    Correlative Assessment of p53 Immunostaining Patterns and TP53 Mutation Status by Next-Generation Sequencing in High-Grade Endometrial Carcinomas.
    Int J Gynecol Pathol. 2023;42:567-575.
    >> Share

  15. ALNA'IRAT M, McCluggage WG, Al-Hussaini M
    Ovarian Immature Teratoma With Nodal Gliomatosis: A Case Report and Literature Review.
    Int J Gynecol Pathol. 2023;42:627-631.
    >> Share

  16. STOLNICU S, Bartalis RJ, Ye Q, Da Cruz Paula A, et al
    Ovarian RASoma With Mesonephric-like Adenocarcinoma and Mixed Mullerian Components: A Case Report With Molecular Analysis Demonstrating Multidirectional Mullerian Differentiation.
    Int J Gynecol Pathol. 2023;42:620-626.
    >> Share

  17. LIN LH, Zamuco RD, Shukla PS
    Ovarian Clear Cell Carcinoma and Markers of Epithelial-Mesenchymal Transition (EMT): Immunohistochemical Characterization of Tumor Budding.
    Int J Gynecol Pathol. 2023;42:602-612.
    >> Share

    October 2023
  18. BICER E, Bese T, Tuzun DD, Ilvan S, et al
    The Relationship Between Melatonin 1-2 Receptor Expression in Patients With Epithelial Ovarian Cancer and Survival.
    Int J Gynecol Pathol. 2023 Oct 4. doi: 10.1097/PGP.0000000000000968.
    >> Share

    September 2023
  19. KEANE E, Floyd R, McDonnell C, Beirne JP, et al
    Endometrioid Adenocarcinoma Resembling Cutaneous Pilomatrix Carcinoma: A Case Report of an Aggressive Neoplasm in a Young Woman With Diffusely Aberrant Beta-catenin Expression and Associated Morular Metaplasia and Atypical Polypoid Adenomyoma-type Cha
    Int J Gynecol Pathol. 2023;42:466-471.
    >> Share

  20. DYHDALO KS, Ababneh E, Lanigan C, Bowers K, et al
    Evaluation of Lineage/Site-specific Nuclear Immunohistochemical Markers SATB2, Cyclin D1, SALL4, and BCOR in High-grade Endometrial Carcinomas.
    Int J Gynecol Pathol. 2023;42:443-450.
    >> Share

  21. KEYHANIAN K, Yang EJ, Howitt BE
    Nuclear beta-Catenin Expression in the Context of Abnormal p53 Expression Indicates a Nonserous Histotype in Endometrial Carcinoma.
    Int J Gynecol Pathol. 2023;42:435-442.
    >> Share

  22. TALIA KL, Ratnayake G, McCluggage WG
    Microscopic Sertoliform Sex Cord Proliferation Involving Pelvic Peritoneum: Report of a Case Associated With Endosalpingiosis.
    Int J Gynecol Pathol. 2023;42:496-499.
    >> Share

  23. DONTHI D, Chen H, Peng Y, Niu S, et al
    Ovarian Microcystic Stromal Tumor With Intraovarian Recurrence and Peritoneal and Omental Spread: A Case Report With Morphological, Immunohistochemical, and Molecular Analysis.
    Int J Gynecol Pathol. 2023;42:491-495.
    >> Share

  24. CHIESA-VOTTERO AG
    Ovarian Mucinous Borderline Tumor With Intraepithelial Carcinoma.
    Int J Gynecol Pathol. 2023;42:514.
    >> Share

  25. GUERRIERI C, Hudacko R, Anderson P
    Composite FOXL2 Mutation-positive Adult Granulosa Cell Tumor and Serous Borderline Tumor of the Ovary.
    Int J Gynecol Pathol. 2023;42:500-507.
    >> Share

  26. CHUI MH, Murali R, Soslow RA, Matrai C, et al
    Interobserver Reproducibility in Assessing Eosinophilic Cells in Ovarian Serous Borderline Tumors to Predict BRAF Mutational Status.
    Int J Gynecol Pathol. 2023;42:472-481.
    >> Share

  27. ANDRADE LALA, Alame M, Truffaux N, Croce S, et al
    Adult Granulosa Cell Tumour With Heterologous Adipocytic Differentiation: Report of a Unique Case.
    Int J Gynecol Pathol. 2023;42:508-513.
    >> Share

    July 2023
  28. CHUI MH, Grisham RN
    Somatic BAP1 Loss in Ovarian Serous Borderline Tumor and Recurrent Low-grade Serous Carcinoma From a Germline BAP1 Mutation Carrier.
    Int J Gynecol Pathol. 2023;42:432-433.
    >> Share

  29. TALHOUK A, Jamieson A, Crosbie EJ, Taylor A, et al
    Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing Protocol.
    Int J Gynecol Pathol. 2023;42:353-363.
    >> Share

  30. BRAUN A, Reddy S, Cheng L, Gattuso P, et al
    Clinicopathologic Review of Metastatic Breast Cancer to the Gynecologic Tract.
    Int J Gynecol Pathol. 2023;42:414-420.
    >> Share

  31. HALL KC, Post MD, Alldredge J, Aisner DL, et al
    Molecular Evidence for Epithelial Origin of Mixed Ovarian Epithelial-Germ Cell Neoplasms: Report of 2 Cases and Review of Literature.
    Int J Gynecol Pathol. 2023;42:403-413.
    >> Share

  32. KOSTELECKY N, Ozhegov E, Cao D, Krigman H, et al
    Metastatic Cholangiocarcinoma to the Uterus Morphologically Imitating Primary Intestinal-type Endometrioid Adenocarcinoma.
    Int J Gynecol Pathol. 2023;42:398-402.
    >> Share

  33. LAU JCC, McCluggage WG, Yuen LYP, Shing MMK, et al
    DICER1 -Altered Extraovarian Moderately Differentiated Sertoli-Leydig Cell Tumor: Report of a Rare Case.
    Int J Gynecol Pathol. 2023;42:421-425.
    >> Share

  34. SUN Y, Liu-Jarin X, Hamele-Bena D, Murty VV, et al
    Ovarian Malignant Mixed Germ Cell Tumor With Prominent Embryoid Bodies (Polyembryoma Background): A Case Report and Literature Review.
    Int J Gynecol Pathol. 2023;42:426-431.
    >> Share

    May 2023
  35. STRICKLAND AL, Maniar KP, Tanner E, Shanes E, et al
    Borderline With Bad Behavior: An Unusual Low-grade Serous Carcinoma With Dedifferentiation From a Serous Borderline Tumor.
    Int J Gynecol Pathol. 2023;42:241-246.
    >> Share

  36. YOSHIDA H, Uno M, Ogimoto K, Kobayashi-Kato M, et al
    Endometrioid Endometrial Carcinoma With NKX3.1 Expression in a Transgender Man: A Case Report.
    Int J Gynecol Pathol. 2023;42:308-314.
    >> Share

  37. OMO-OGBOI AC, Deavers MT, Schmeler KM, Tandon N, et al
    Collision Tumor of the Ovary Involving Sertoli-Leydig Cell Tumor and High-Grade Serous Carcinoma-Report of the First Case.
    Int J Gynecol Pathol. 2023;42:254-258.
    >> Share

  38. MENDOZA R, Kertowidjojo E
    CTNNB1 -mutated High-grade Endometrioid Carcinoma With Extensive Squamous and Shadow Cell Differentiation Can Mimic Pilomatrix Carcinoma.
    Int J Gynecol Pathol. 2023;42:325-326.
    >> Share

  39. HALLING GC, Udager AM, Skala SL
    Endometrial, Ovarian, and Peritoneal Involvement by Endometrioid Carcinoma, Yolk Sac Tumor, and Endometriosis: Molecular Evidence for a Shared Precursor.
    Int J Gynecol Pathol. 2023;42:247-253.
    >> Share

    March 2023
  40. DEVINS KM, Zukerberg L, Watkins JC, Hung YP, et al
    BAP1 and Claudin-4, But Not MTAP, Reliably Distinguish Borderline and Low-grade Serous Ovarian Tumors From Peritoneal Mesothelioma.
    Int J Gynecol Pathol. 2023;42:159-166.
    >> Share

  41. MCHENRY A, Buza N
    Anastomosing Hemangioma of the Ovary With Leydig Cell Hyperplasia: A Clinicopathologic Study of 12 Cases.
    Int J Gynecol Pathol. 2023;42:167-175.
    >> Share

  42. NILFOROUSHAN N, Liu L, Finkelman BS, Andersen J, et al
    Ovarian Combined Serous Borderline Tumor/Low-grade Serous Carcinoma and Mesonephric-like Lesion: Report of 2 Cases With New Observations.
    Int J Gynecol Pathol. 2023;42:182-191.
    >> Share

  43. DUNDAR B, Alrwashdeh A, Dahmoush L
    Tumor to Tumor Metastasis: A Case Report of Metastatic Angiosarcoma to an Ovarian Brenner Tumor and Review of the Literature.
    Int J Gynecol Pathol. 2023;42:176-181.
    >> Share

  44. BANET N, Masnick M, Quddus MR
    Evaluation of Saccharomyces cerevisiae -like 1 (SEC14L1) in Gynecologic Malignancies Shows Overexpression in Endometrial Serous Carcinoma.
    Int J Gynecol Pathol. 2023;42:136-142.
    >> Share

    January 2023
  45. COPPOCK JD, Gradecki SE, Mills AM
    PRAME Expression in Endometrioid and Serous Endometrial Carcinoma: A Potential Immunotherapeutic Target and Possible Diagnostic Pitfall.
    Int J Gynecol Pathol. 2023;42:35-42.
    >> Share

  46. KOUCHI Y, Komatsu S, Harada S, Shinomiya Y, et al
    Ovarian Malignant Mixed Germ Cell Tumor Composed Mainly of a Polyembryoma Pattern With Vasculogenic Mesenchymal Tumor Components.
    Int J Gynecol Pathol. 2023;42:78-82.
    >> Share

  47. ALBRIGHT BB, Wignall E, Bentley RC, Havrilesky LJ, et al
    BAP1 Tumor Predisposition Syndrome Presenting as a Recurrent Ovarian Sex Cord-Stromal Tumor.
    Int J Gynecol Pathol. 2023;42:83-88.
    >> Share

  48. TALIA KL, McCluggage WG
    Microscopic Sertoliform Sex Cord Proliferations: A Rare Incidental Finding Associated With Endometriosis and Ovarian Epithelial Neoplasia.
    Int J Gynecol Pathol. 2023;42:70-77.
    >> Share

  49. HAAG JG, Wolsky RJ, Moroney MR, Sheren J, et al
    Clinicopathologic Evaluation of CTNNB1 Mutations in High-Intermediate Risk Endometrial Endometrioid Carcinoma.
    Int J Gynecol Pathol. 2023;42:43-53.
    >> Share

  50. CHANG CS, Carney ME, Killeen JL
    Two Cases of Mesonephric-like Carcinoma Arising From Endometriosis: Case Report and Review of the Literature.
    Int J Gynecol Pathol. 2023;42:101-107.
    >> Share

  51. ARCIUOLO D, Travaglino A, Santoro A, Roberti P, et al
    Pilomatrix-like High-grade Endometrioid Carcinoma is a Morphologically and Immunophenotypically Distinct Entity and May Show Mismatch Repair Deficiency.
    Int J Gynecol Pathol. 2023;42:68-69.
    >> Share

  52. GREGORY-DAVIS KJ, Walker A, Colello LS, McKinnon W, et al
    Serous Tubal Intraepithelial Carcinoma in a Risk-reducing Salpingo-oophorectomy Specimen From a RAD51D Mutation Carrier: A Case Report.
    Int J Gynecol Pathol. 2023;42:89-92.
    >> Share

  53. MCMULLEN-TABRY ER, Sciallis AP, Udager AM, Skala SL, et al
    Unusual Ovarian Tumors With Endometrioid Proliferations Co-Expressing Estrogen Receptor and CDX-2 Arising in Cystadenofibromatous Background: Report of 3 Cases.
    Int J Gynecol Pathol. 2023;42:93-100.
    >> Share

  54. SHARMA AE, Moran A, Somasegar S, Steinhardt G, et al
    Clinicopathologic Evaluation and Molecular Profiling of Recurrent Stage IA Endometrial Endometrioid Carcinoma: A Case-control Study.
    Int J Gynecol Pathol. 2023;42:26-34.
    >> Share

  55. YIN X, Wang M, He H, Ru G, et al
    Uterine Tumor Resembling Ovarian Sex Cord Tumor With Aggressive Histologic Features Harboring a GREB1-NCOA2 Fusion: Case Report With a Brief Review.
    Int J Gynecol Pathol. 2023;42:54-62.
    >> Share

    November 2022
  56. GILL SJ, Pirzada A, Power P, Neveu J, et al
    A Constellation of Rare Gynecological Malignancies and Familial Adenomatous Polyposis Gastrointestinal Adenocarcinoma: A Case Report.
    Int J Gynecol Pathol. 2022;41:622-627.
    >> Share

  57. ARCIUOLO D, Travaglino A, Santoro A, Pedone Anchora L, et al
    Postchemotherapy Endometrioid to Gastrointestinal Histotype Shift in Recurrent Endometrial Carcinoma.
    Int J Gynecol Pathol. 2022;41:583-587.
    >> Share

  58. SAUER MA, Coy S, Quade BJ, Nucci MR, et al
    Well-developed Cerebellum in an Ovarian Mature Teratoma From a Pregnant Female.
    Int J Gynecol Pathol. 2022;41:615-621.
    >> Share

  59. DEVEREAUX KA, Steiner DF, Ho C, Gomez AJ, et al
    A Multiplex SNaPshot Assay is a Rapid and Cost-Effective Method for Detecting POLE Exonuclease Domain Mutations in Endometrial Carcinoma.
    Int J Gynecol Pathol. 2022;41:541-551.
    >> Share

  60. DAHOUD W, Handler J, Parimi V, Meyer CF, et al
    Adult Granulosa Cell Tumor With Sarcomatous Transformation: A Case Study With Emphasis on Molecular Alterations.
    Int J Gynecol Pathol. 2022;41:600-607.
    >> Share

    July 2022
  61. AKBARZADEH-JAHROMI M, Aslani FS, Raeisi H, Momtahan M, et al
    Comparison of Frozen and Permanent Section Diagnosis in Ovarian Neoplasms: Analysis of Factors Affecting Accuracy.
    Int J Gynecol Pathol. 2022;41:327-336.
    >> Share

  62. SHETTY D, Bhalekar S, Rao S, Mukharji S, et al
    Cystic Ovarian Mucinous Carcinoma With Carcinosarcomatous Mural Nodules: An Uncommon Entity.
    Int J Gynecol Pathol. 2022;41:343-348.
    >> Share

  63. MCCLUGGAGE WG, Fu L, Mohler K, de Kock L, et al
    An Unusual Enteric Yolk Sac Tumor: First Report of an Ovarian Germ Cell Tumor Associated With a Germline Pathogenic Variant in DICER1.
    Int J Gynecol Pathol. 2022;41:349-355.
    >> Share

  64. MATSON DR, Accola MA, Henderson L, Shao X, et al
    A "Null" Pattern of p16 Immunostaining in Endometrial Serous Carcinoma: An Under-recognized and Important Aberrant Staining Pattern.
    Int J Gynecol Pathol. 2022;41:378-388.
    >> Share

  65. LU B, Shi H, Shao Y, Xu J, et al
    Ovarian Metastasis by Gastric-type Endocervical Adenocarcinoma: A Clinicopathologic Description of 12 Cases.
    Int J Gynecol Pathol. 2022;41:356-365.
    >> Share

  66. GUIDO LP, Camacho F, Freire R, Pinto A, et al
    Unusual Variants of Teratoma Involving the Gynecologic Tract.
    Int J Gynecol Pathol. 2022;41:320-326.
    >> Share

  67. PARRA-HERRAN C
    Endometrioid Tubal Intraepithelial Neoplasia and Bilateral Ovarian Microcystic Stromal Tumors Harboring APC Mutations: Report of a Case.
    Int J Gynecol Pathol. 2022;41:337-342.
    >> Share

    May 2022
  68. MATRAI CE, Ohara K, Eng KW, Glynn SM, et al
    Molecular Evaluation of Low-grade Low-stage Endometrial Cancer With and Without Recurrence.
    Int J Gynecol Pathol. 2022;41:207-219.
    >> Share

  69. PETERS EEM, Leon-Castillo A, Hogdall E, Boennelycke M, et al
    Substantial Lymphovascular Space Invasion Is an Adverse Prognostic Factor in High-Risk Endometrial Cancer.
    Int J Gynecol Pathol. 2022;41:227-234.
    >> Share

  70. MCMULLEN ER, Huang T, Skala SL
    Large Ovarian Follicle Cyst: Benign Mimic of Cystic Adult Granulosa Cell Tumor.
    Int J Gynecol Pathol. 2022;41:289-291.
    >> Share

  71. MCGINN B, Lemaire AS, McCluggage WG
    Ovarian Low-grade Basaloid Carcinoma Arising in Brenner Tumor: A New Variant of Malignant Brenner Tumor.
    Int J Gynecol Pathol. 2022;41:276-284.
    >> Share

    March 2022
  72. GANESAN R, Gilks CB, Soslow RA, McCluggage WG, et al
    Survey on Reporting of Endometrial Biopsies From Women on Progestogen Therapy for Endometrial Atypical Hyperplasia/Endometrioid Carcinoma.
    Int J Gynecol Pathol. 2022;41:142-150.
    >> Share

  73. WEISMAN P, Park KJ, Xu J
    FIGO Grade 3 Endometrioid Adenocarcinomas With Diffusely Aberrant beta-Catenin Expression: An Aggressive Subset Resembling Cutaneous Pilomatrix Carcinomas.
    Int J Gynecol Pathol. 2022;41:126-131.
    >> Share

  74. RAJENDRAN S, McCluggage WG
    WT1 Positive Ovarian Endometrioid Tumors: Observations From Consult Cases and Strategies for Distinguishing From Serous Neoplasms.
    Int J Gynecol Pathol. 2022;41:191-202.
    >> Share

  75. CAGAANAN A, Stelter B, Vu N, Rhode EN, et al
    HER2 Expression in Endometrial Cancers Diagnosed as Clear Cell Carcinoma.
    Int J Gynecol Pathol. 2022;41:132-141.
    >> Share

  76. RAJENDRAN S, Boyd C, Shah R, Stewart CJR, et al
    Bronchus-like Structures in Ovarian Teratomas: Report of a Series of a Previously Unreported Phenomenon With Potential For Misdiagnosis.
    Int J Gynecol Pathol. 2022;41:180-185.
    >> Share

  77. WIEDEMEYER K, Wang L, Kang EY, Liu S, et al
    Prognostic and Theranostic Biomarkers in Ovarian Clear Cell Carcinoma.
    Int J Gynecol Pathol. 2022;41:168-179.
    >> Share

    January 2022
  78. VROOBEL KM, McCluggage WG
    Ovarian Clear Cell Tumors Associated With Seromucinous Borderline Tumor: A Case Series.
    Int J Gynecol Pathol. 2022;41:76-81.
    >> Share

  79. SHAH VI, Morgan SE, Kobel M, Lee CH, et al
    Dedifferentiation in Breast Metastasis of Endometrial Carcinoma: A Diagnostic Dilemma.
    Int J Gynecol Pathol. 2022;41:35-39.
    >> Share

  80. WANG L, Piskorz A, Bosse T, Jimenez-Linan M, et al
    Immunohistochemistry and Next-generation Sequencing Are Complementary Tests in Identifying PTEN Abnormality in Endometrial Carcinoma Biopsies.
    Int J Gynecol Pathol. 2022;41:12-19.
    >> Share

  81. WATKINS JC, Young RH
    Mullerian Mucinous Cystadenomas of the Ovary: A Report of 25 Cases of an Unheralded Benign Ovarian Neoplasm Often Associated With Endometriosis and a Brief Consideration of Neoplasms Arising From the Latter.
    Int J Gynecol Pathol. 2022;41:68-75.
    >> Share

  82. CAO J, Hacking S, Chavarria-Bernal HD, Bhuiya TA, et al
    Androgen Receptor Immunohistochemical Expression in Undifferentiated/Dedifferentiated Endometrial Carcinoma.
    Int J Gynecol Pathol. 2022;41:28-34.
    >> Share

    November 2021
  83. KWON DH, Malpica A, Zaleski M, Euscher ED, et al
    Immunohistochemical Loss of DPC4 in Tumors With Mucinous Differentiation Arising in or Involving the Gynecologic Tract.
    Int J Gynecol Pathol. 2021;40:523-532.
    >> Share

  84. ABU-SINN D, Jamison J, Evans M, McCluggage WG, et al
    Pelvic and Ovarian Recurrence of Small HPV-associated Cervical Adenocarcinoma With Transformation to Neuroendocrine Carcinoma.
    Int J Gynecol Pathol. 2021;40:541-548.
    >> Share

  85. JHA S, Mitra S, Patra S, Sethi P, et al
    Krukenberg Tumor of Ovary During Pregnancy: Learning From A Mistake.
    Int J Gynecol Pathol. 2021;40:617-620.
    >> Share

  86. KARPATHIOU G, Chauleur C, Dal Col P, Peoc'h M, et al
    FOXA1 Expression by Immunohistochemistry in Carcinosarcomas of the Endometrium and Ovary/Fallopian Tube.
    Int J Gynecol Pathol. 2021;40:611-616.
    >> Share

    September 2021
  87. OLIVADESE R, Ramponi A, Boldorini R, Dalla Dea G, et al
    Mitotically Active Cellular Fibroma of the Ovary Recurring After the Longest Interval of Time (16 yr): A Challenging Case With Systematic Literature Review.
    Int J Gynecol Pathol. 2021;40:441-447.
    >> Share

  88. CATTEAU X, Preat F, D'haene N, Noel JC, et al
    Osseous Metaplasia in Low-grade Ovarian Serous Carcinoma With a BRAF Mutation: A Case Report.
    Int J Gynecol Pathol. 2021;40:448-451.
    >> Share

  89. NAGAR R, Peters T, Nagar H, McCluggage WG, et al
    Diagnostic Accuracy in Assessment of Depth of Myometrial Invasion in Low-grade Endometrioid Carcinoma: A 2 Center Comparative Study by MRI and Intraoperative Assessment.
    Int J Gynecol Pathol. 2021;40:495-500.
    >> Share

    July 2021
  90. LAI J, Garvey KY, Li P, Azevedo RA, et al
    Primary Ovarian Melanoma Arising From a Mature Teratoma With Melanoma In Situ Present in the Ciliated Columnar and Squamous Epithelium in a Patient With Synchronous Skin Basal Cell Carcinoma.
    Int J Gynecol Pathol. 2021;40:383-390.
    >> Share

  91. D'ANTONIO A, Caleo A, Addesso M, Caputo A, et al
    A Rare Case of Castleman Disease Presenting as an Ovarian Tumor.
    Int J Gynecol Pathol. 2021;40:379-382.
    >> Share

  92. SALISBURY T, Gilks CB
    Immunoreactive Acellular Keratin in Sentinel Lymph Nodes From a Patient With Endometrioid Carcinoma of the Endometrium With Squamous Differentiation: A Case Report of a Potential Diagnostic Pitfall.
    Int J Gynecol Pathol. 2021;40:355-358.
    >> Share

  93. WATKINS JC, Young RH
    Follicle Cysts of the Ovary: A Report of 30 Cases of a Common Benign Lesion Emphasizing its Unusual Clinical and Pathologic Aspects.
    Int J Gynecol Pathol. 2021;40:359-368.
    >> Share

  94. HEIMBIGNER AM, Davaro EP, Schwetye K
    Benign Brenner Tumor in an Ectopic Ovary: A Case Report and Review of Literature.
    Int J Gynecol Pathol. 2021;40:376-378.
    >> Share

    May 2021
  95. ZHANG L, Velazquez M, Wang X, Masand R, et al
    Ovarian Mixed Epithelial Carcinoma With Extensive Bilateral Fallopian Tubes Metastases by the Low-grade Serous Carcinoma Component Mimicking Serous Tubal Intraepithelial Carcinoma: Case Presentation and Literature Review.
    Int J Gynecol Pathol. 2021;40:305-309.
    >> Share

  96. WRIGHT MF, Fitzlaff S, Wyeth A, Zaragoza-Watkins M, et al
    Nuclear Beta-Catenin Expression in Endometrioid Intraepithelial Neoplasia (Atypical Hyperplasia) Does Not Predict Carcinoma on Subsequent Hysterectomy.
    Int J Gynecol Pathol. 2021;40:240-247.
    >> Share

  97. HODGSON A, Ghorab Z, Parra-Herran C
    Somatically Derived Yolk Sac Tumor of the Ovary in a Young Woman.
    Int J Gynecol Pathol. 2021;40:296-300.
    >> Share

  98. HALVORSON TS, Robinson RA, Samuelson MI
    Pure Primary Ovarian Carcinoid Tumor.
    Int J Gynecol Pathol. 2021;40:301-304.
    >> Share

  99. SHARMA AE, Hamedani FS, Barroeta JE, Pytel P, et al
    Clear Cell Papillary Cystadenoma of the Ovary Masquerading as Metastatic Clear Cell Renal Cell Carcinoma: A Case Report and Review of the Literature.
    Int J Gynecol Pathol. 2021;40:290-295.
    >> Share

    March 2021
  100. LADWIG NR, Umetsu SE, Zaloudek C, Rabban J, et al
    Corded and Hyalinized Endometrioid Adenocarcinoma (CHEC) of the Uterine Corpus are Characterized by CTNNB1 Mutations and Can Show Adverse Clinical Outcomes.
    Int J Gynecol Pathol. 2021;40:103-115.
    >> Share

  101. BENNETT JA, Safdar N, Segal JP, Lastra RR, et al
    Evaluation of SWI/SNF Protein Expression by Immunohistochemistry in Ovarian Clear Cell Carcinoma.
    Int J Gynecol Pathol. 2021;40:156-164.
    >> Share

  102. GUERRIERI C, Anderson P, Hudacko R
    Ciliated Carcinoma of the Endometrium.
    Int J Gynecol Pathol. 2021;40:141-147.
    >> Share

  103. LIN SY, Hang JF, Lin YY, Lai CR, et al
    Diffuse Intratumoral Stromal Inflammation in Ovarian Clear Cell Carcinoma is Associated With Loss of Mismatch Repair Protein and High PD-L1 Expression.
    Int J Gynecol Pathol. 2021;40:148-155.
    >> Share

  104. BRETT MA, Atenafu EG, Singh N, Ghatage P, et al
    Equivalent Survival of p53 Mutated Endometrial Endometrioid Carcinoma Grade 3 and Endometrial Serous Carcinoma.
    Int J Gynecol Pathol. 2021;40:116-123.
    >> Share

  105. KATSAKHYAN L, Baraban EG, Dumoff KL, Burger RA, et al
    The "Far Left" of the Morphologic Spectrum of Ovarian High-grade Serous Carcinoma: Case Report of a Purely Noninvasive High-grade Serous Carcinoma Mimicking an Ovarian Serous Borderline Tumor.
    Int J Gynecol Pathol. 2021;40:175-179.
    >> Share

    January 2021
  106. KOBEL M, Kang EY
    The Many Uses of p53 Immunohistochemistry in Gynecological Pathology: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual9 Meeting.
    Int J Gynecol Pathol. 2021;40:32-40.
    >> Share

  107. TAYLOR J, Shah R, McElvanna K, Kelly PJ, et al
    Late Development of Metastatic Ovarian Mucinous Adenocarcinoma From Primary Gallblader Adenocarcinoma and High-grade Dysplasia.
    Int J Gynecol Pathol. 2021;40:41-48.
    >> Share

  108. CRASTA J, Ravikumar G, Rajarajan S, Gali S, et al
    Expression of HER2 and EGFR Proteins in Advanced Stage High-grade Serous Ovarian Tumors Show Mutual Exclusivity.
    Int J Gynecol Pathol. 2021;40:49-55.
    >> Share

  109. STEWART CJR, Harding S
    Stromal Endocrine Cell Micronests Associated With an Ovarian Mucinous Cystadenoma: Endocrine Cell Preservation (Pseudohyperplasia) Potentially Mimicking Stromal Sex Cord Proliferation or Tumor Microinvasion.
    Int J Gynecol Pathol. 2021;40:56-59.
    >> Share

    July 2020
  110. FEDDA FA, Euscher ED, Ramalingam P, Malpica A, et al
    Prophylactic Risk-reducing Hysterectomies and Bilateral Salpingo-oophorectomies in Patients With Lynch Syndrome: A Clinicopathologic Study of 29 Cases and Review of the Literature.
    Int J Gynecol Pathol. 2020;39:313-320.
    >> Share

  111. TRENTO M, Munari G, Carraro V, Lanza C, et al
    Mutational and Immunophenotypic Profiling of a Series of 8 Tubo-ovarian Carcinosarcomas Revealed a Monoclonal Origin of the Disease.
    Int J Gynecol Pathol. 2020;39:305-312.
    >> Share

  112. LENGYEL K, Young F, Kucukmetin A, Cresti N, et al
    BRAF Wild-type, PTEN Mutant Malignant Uveal Melanoma Arising Within a Mature Ovarian Teratoma: A Case Report and Review of the Literature.
    Int J Gynecol Pathol. 2020;39:321-326.
    >> Share

  113. ABBAS A, Ud Din N, Kayani N
    Synchronous Well-differentiated Endometrioid Adenocarcinoma and Leiomyosarcoma of the Uterus With Pulmonary Metastasis in a 50-Yr-Old Woman: A Case Report and Review of Literature.
    Int J Gynecol Pathol. 2020;39:373-378.
    >> Share

    May 2020
  114. ABOZINA A, Singh N, Blake C
    Transtubal Spread of a Superficially Invasive Cervical Adenocarcinoma to the Ovaries After 11 Years.
    Int J Gynecol Pathol. 2020;39:296-300.
    >> Share

  115. MEYDANLI MM, Aslan K, Oz M, Muftuoglu KH, et al
    Is It Possible to Develop a Prediction Model for Lymphovascular Space Invasion in Endometrioid Endometrial Cancer?
    Int J Gynecol Pathol. 2020;39:213-220.
    >> Share

  116. FAHOUM I, Brazowski E, Hershkovitz D, Aizic A, et al
    Tumor-to-Tumor Metastasis of Colorectal Adenocarcinoma to Ovarian Cystadenofibroma: A Case Report and Review of the Literature.
    Int J Gynecol Pathol. 2020;39:270-272.
    >> Share

  117. CHAPEL DB, Lengyel E, Ritterhouse LL, Lastra RR, et al
    Interpretation of Mismatch Repair Protein Immunohistochemistry in Endometrial Carcinoma Should Consider Both Lynch Syndrome Screening and Immunotherapy Susceptibility: An Illustrative Case Report.
    Int J Gynecol Pathol. 2020;39:233-237.
    >> Share

    March 2020
  118. BROUWER J, Strickland KC, Ning G, Schmelkin CB, et al
    Evidence for a Novel Endometrioid Carcinogenic Sequence in the Fallopian Tube With Unique Beta-Catenin Expression.
    Int J Gynecol Pathol. 2020;39:163-169.
    >> Share

  119. ZHANG X, Guo J, Yang L, Zhao Y, et al
    Ovarian Sclerosing Stromal Tumor and Mullerian Cyst in an 11-yr-old Girl: A Case Report and Review of the Literature.
    Int J Gynecol Pathol. 2020;39:e5-e10.
    >> Share

  120. BAI S, Hutchinson LM, Meng X, Bai H, et al
    Dedifferentiated Carcinoma of the Endometrium Associated With Low-grade Mullerian Adenosarcoma: A Clinicopathologic Case Report Including the Immunohistochemical and Molecular Profile.
    Int J Gynecol Pathol. 2020;39:141-145.
    >> Share

  121. VOS MC, Hollemans E, van der Steen SCHA, van Kuppevelt TH, et al
    Primary Ovarian Tumors With Lymphogenic and Hematogenic Metastasis Express High MMP-14, Which Colocalizes With Highly Sulfated Chondroitin Sulfate in the Stroma.
    Int J Gynecol Pathol. 2020;39:184-192.
    >> Share

  122. COSTIGAN DC, Dong F, Nucci MR, Howitt BE, et al
    Clinicopathologic and Immunohistochemical Correlates of CTNNB1 Mutated Endometrial Endometrioid Carcinoma.
    Int J Gynecol Pathol. 2020;39:119-127.
    >> Share

  123. CHEN PH, Hui P, Buza N
    Bilateral Signet-ring Stromal Tumor of the Ovary: A Case Report With Next-generation Sequencing Analysis and FOXL2 Mutation Testing.
    Int J Gynecol Pathol. 2020;39:193-198.
    >> Share

  124. CHIESA-VOTTERO A
    CDX2, SATB2, GATA3, TTF1, and PAX8 Immunohistochemistry in Krukenberg Tumors.
    Int J Gynecol Pathol. 2020;39:170-177.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016